ADAM22 anticorps (N-Term)
Aperçu rapide pour ADAM22 anticorps (N-Term) (ABIN928107)
Antigène
Voir toutes ADAM22 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Souris
-
Purification
- Purified
-
Immunogène
- Adam22 antibody was raised in rabbit using the N terminal of Adam22 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
Adam22 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this Adam22 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ADAM22 (ADAM Metallopeptidase Domain 22 (ADAM22))
-
Autre désignation
- Adam22
-
Sujet
- Adam22 is a probable ligand for integrin in the brain. This is a non catalytic metalloprotease-like protein. Adam22 is involved in regulation of cell adhesion and spreading and in inhibition of cell proliferation.Adam22 is asneuronal receptor for LGI1. Synonyms: Polyclonal Adam22 antibody, Anti-Adam22 antibody, a disintegrin and metallopeptidase domain 22 antibody, 2900022I03Rik antibody, AI854032 antibody, MDC2 antibody.
Antigène
-